Incidence and predictors of hepatocellular carcinoma in Caucasian chronic hepatitis B patients receiving entecavir or tenofovir

Papatheodoridis, ONUR; Dalekos, George; Yurdaydin, Cihan; Buti, Maria; Goulis, John; Arends, Pauline; Sypsa, Vana; Manolakopoulos, Spilios; Mangia, Giampaolo; Gatselis, Nikolaos; KESKİN, ONUR; Savvidou, Savvoula; Hansen, Bettina; Papaioannou, Christos; Galanis, Kostantinos; İDİLMAN, RAMAZAN; Colombo, Massimo; Esteban, Rafael; Janssen, Harry; Lampertico, Pietro

doi:10.1016/j.jhep.2014.08.045

Incidence and predictors of hepatocellular carcinoma in Caucasian chronic hepatitis B patients receiving entecavir or tenofovir

Copy For Citation

Papatheodoridis G. V., Dalekos G. N., Yurdaydin C., Buti M., Goulis J., Arends P., ...More

JOURNAL OF HEPATOLOGY, vol.62, no.2, pp.363-370, 2015 (SCI-Expanded)

Publication Type: Article / Article
Volume: 62 Issue: 2
Publication Date: 2015
Doi Number: 10.1016/j.jhep.2014.08.045
Journal Name: JOURNAL OF HEPATOLOGY
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.363-370
Hacettepe University Affiliated: No

Abstract

Background & Aims: The risk of hepatocellular carcinoma (HCC) in Caucasian patients with chronic hepatitis B (CHB), treated with entecavir (ETV) or tenofovir (TDF), is unclear. We evaluated the incidence and predictors of HCC and the accuracy of existing HCC risk scores in Caucasian CHB patients receiving ETV/TDF.